Explore the latest in ethics, including topics in clinical, research, and publication ethics.
This Viewpoint describes transparency practices that could help physicians build trust with patients and model professionalism for students and trainees: clear and consistent disclosure of financial relationships, conflicts of interest, credentials, disciplinary actions, performance metrics, and personal information or experiences oriented toward improving patient outcomes.
This cohort study compares the New York State Ventilator Allocation Guideline with the original triage criteria proposed by White and Lo to determine which and how many admissions to US intensive care units are identified as having the lowest priority for ventilator allocation.
This Viewpoint proposes that prioritizing all placebo-group participants in coronavirus vaccine trials as vaccine first receivers could perpetuate health inequities and compromise the chance to learn from their participation, proposing instead to limit prioritization to placebo participants who would be prioritized for vaccination anyway under NASEM or ACIP frameworks.
This Viewpoint discusses the ethics of including a placebo arm in randomized trials of coronavirus vaccines once authorized vaccines have become widely available, and proposes use of adaptive platform trial designs as an optimal approach to nimbly and ethically compare future investigational COVID-19 vaccines with proven effective ones.
This Viewpoint discusses the need to account for neonates and children—who are typically disproportionally impacted during pandemics—by implementing hospital resource allocation protocols that ensure equity across the life span.
This cohort study of Chinese-sponsored randomized clinical trials assesses incidence of duplicate publication and the extent to which duplicate publication is associated with the language of publication.
This cross-sectional study examines the implication of US state crisis standards of care guideline recommendations for patients with cancer, including allocation methods, cancer-related categorical exclusions and deprioritizations, and provisions for blood products and palliative care.
This Viewpoint discusses questions about clinical indication, supply, distribution, and cost and coverage that will need to be resolved if monoclonal antibodies are be granted Emergency Use Authorization or licensure and become available as treatment for COVID-19.
This study examines payments from medical device and pharmaceutical companies compiled in the Open Payments Database to physician-authors of the Congress of Neurological Surgery’s clinical practice guidelines.
This Viewpoint discusses the modern history of US presidential disability and efforts to balance the chief executive’s confidentiality with the public’s right to know, and calls for clearer guidelines from trusted physician organizations to inform bipartisan cabinet and congressional assessments of physical and psychiatric fitness to hold office.
This Viewpoint considers how COVID-19 vaccines can be distributed strategically, ethically, and legally given conflicts between consensus public health recommendations to prioritize allocation to disadvantaged racial and ethnic minorities and laws discouraging explicit consideration of race in policy decisions.
This Viewpoint summarizes the principles guiding coronavirus disease 2019 (COVID-19) vaccine recommendations made by the Advisory Committee on Immunization Practices (ACIP), a nongovernment advisory standing committee that counsels the Centers for Disease Control and Prevention on US population vaccine use, emphasizing that any final recommendations await phase 3 safety and efficacy data from ongoing trials.
This qualitative study used a mixed-methods approach to analyze survey and narrative data on how professionalism standards are operationalized and perceived in diverse health care work and learning environments.
This Viewpoint discusses the role of adolescents in decisions about their health care, particularly potentially life-saving interventions.
In this narrative medicine essay, a Brigham and Women’s Hospital (BWH) clinician uses the resignation of BWH's president from Moderna's board of directors after a stock sale reportedly paying her millions to question why leaders of academic medical centers are allowed to develop lucrative relationships with industry that prioritize mutual profits over patient well-being and public health.
This study uses Medicare Open Payments data to characterize trends in the prevalence and value of physicians’ interactions with industry overall and by specialty between January 2014 and December 2018 after implementation of the federal Open Payments transparency program in 2013.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: